Albumin Market: Industry Analysis and forecast 2027: By Product Type, Application, End Users and Region

Albumin Market was valued US$ XX Bn in 2018 and is expected to reach US$ 477.84 Bn by 2027, at CAGR of XX% during forecast period of 2019 to 2027. Albumin Market To know about the Research Methodology :- Request Free Sample Report

Albumin Market Drivers and Restrains:

Albumin is a water-soluble globular protein formed in the liver accounting for 50% of blood plasma proteins. Albumin plays an important role in regulating blood volume and act as transporters for molecules like few hormones, bile salts and ions. It is mostly used as blood volumizer in infrequent diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. It supports in the stabilization of drugs by reducing aggregation, oxidation, and surface absorption. Various type of serum albumin are widely used for clinical applications. Human serum albumin and bovine serum albumin are found in human plasma and bovine plasma, respectively. On the other hand, recombinant albumin is manufactured by recombinant techniques in yeast and bacteria strains.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. The albumin market has driven by such factors are increase in incidence of life-threatening disorders and conditions, rising production of immunoglobulin, increasing plasma collection, and high demand for albumin in R&D activities. The albumin market is expected to a significant growth rate in the near future due to improvements in protein purification and molecular separation technology. The irrational uses and adverse reactions associated with albumin, and the rising shift toward serum-free solutions are hampering the market growth at the global level. Furthermore, the development of cost-effective therapeutics along with large scale production of albumin and high potential in untapped markets in the emerging economies are provided lucrative growth opportunities for the albumin market.

Albumin Market Segmentation Analysis:

Based on the product, the albumin market has been segmented into human serum albumin, Bovine Serum Albumin and recombinant albumin. The human serum albumin segment accounted for the dominant market share in 2018, and is expected to continue this trend during the forecast period owing to large amounts of use in the treatment of burns, shock, and blood loss. It is also used in the pharmaceutical preparations, such as drug formulations and vaccines, and in cell culture media. Human serum albumin is the serum albumin originate in human blood. It is the most abundant protein in human blood plasma and constitutes about half of the serum proteins. It is produced in the liver and is soluble and monomeric. The rising formulations and increasing R&D, along with the growing of diseases, are driving the segment growth in the forecast period. Based on the application, the albumin market has been segmented into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizer, diagnostics, In vitro fertilization. The drug delivery segment held for near XX% of the albumin market share in 2018 and this trend is projected to continue over the forecast period. The usage of human serum albumin nanoparticles as a favored drug delivery system with applications for a wide range of diseases are fueling the market growth globally. The ongoing collaborations and joint ventures among the leading manufacturers in the albumin market is likely to offer significant boost to the growth of the market.

Albumin Market Regional Analysis:

Geographically, the Albumin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period due to rise in investments in life sciences by a large number of biopharmaceutical companies and research institutes. Rising demand for albumin is an emerging economies such as India and China. Hence, awareness programs conducted by organizations such as Plasma Protein Therapeutics Association (PPTA), which help to increase awareness about plasma donation and the different plasma protein therapies available along with their potential uses are expected to increase the uptake of these therapeutics in treating various conditions. A report covers the recent development in market for the albumin market like, Serendex Pharmaceutical declared that the company has initiated the phase I trials of Molgradex. This drug candidate is used for treating rare pulmonary diseases. The drug uses Novozymes’ Recombumin, a recombinant human albumin for more effective delivery of the therapeutic to the lungs.

Albumin Market Competitive landscape

Major Key players operating in this market are Albumedix A/S, Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, and Grifols International. Manufacturers in the albumin are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers. The objective of the report is to present comprehensive analysis of albumin market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding albumin market dynamics, structure by analyzing the market segments, and project the albumin market size. Clear representation of competitive analysis of key players by product type, price, financial position, product portfolio, growth strategies, and regional presence in the albumin market make the report investor’s guide.

Scope of the Albumin Market: Inquire before buying

Albumin Market, by Product Type:

• Human Serum Albumin • Recombinant Albumin • Bovine Serum Albumin

Albumin Market, by Application:

• Drug Formulation • Drug Delivery • Vaccines • Medical Device Coating • Culture Medium & Stabilizer • Diagnostics • In Vitro Fertilization

Albumin Market, by End User:

• Pharmaceutical & Biotechnology Industry • Research Institutes

Albumin Market, by Region:

• Asia Pacific • North America • Europe • Latin America • Middle East Africa

Albumin Market, Major Players:

• Albumedix A/S • Albumin Therapeutics, LLC • Biotest AG • CSL Behring LLC • Grifols International, S.A. • HiMedia Laboratories Pvt. Ltd. • InVitria • Medxbio Pte Ltd. • Octapharma AG • RayBiotech, Inc. • SeraCare Life Sciences • Sigma-Aldrich Co. • Akron Biotech • Baxter International Inc. • Celgene Corporation, • Grifols SA • Merck KGaA • China Biologic Products Inc. • Shire Plc • Ventria Bioscience • Thermo Fisher Scientific • Novozymes A/S.
Albumin Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Albumin Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Albumin Market Analysis and Forecast 6.1. Global Albumin Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Albumin Market Analysis and Forecast, by Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Albumin Market Value Share Analysis, by Product Type 7.4. Global Albumin Market Size (US$ Mn) Forecast, by Product Type 7.5. Global Albumin Market Analysis, by Product Type 7.6. Global Albumin Market Attractiveness Analysis, by Product Type 8. Global Albumin Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Albumin Market Value Share Analysis, by Application 8.4. Global Albumin Market Size (US$ Mn) Forecast, by Application 8.5. Global Albumin Market Analysis, by Application 8.6. Global Albumin Market Attractiveness Analysis, by Application 9. Global Albumin Market Analysis and Forecast, by End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Albumin Market Value Share Analysis, by End-User 9.4. Global Albumin Market Size (US$ Mn) Forecast, by End-User 9.5. Global Albumin Market Analysis, by End-User 9.6. Global Albumin Market Attractiveness Analysis, by End-User 10. Global Albumin Market Analysis, by Region 10.1. Global Albumin Market Value Share Analysis, by Region 10.2. Global Albumin Market Size (US$ Mn) Forecast, by Region 10.3. Global Albumin Market Attractiveness Analysis, by Region 11. North America Albumin Market Analysis 11.1. Key Findings 11.2. North America Albumin Market Overview 11.3. North America Albumin Market Value Share Analysis, by Product Type 11.4. North America Albumin Market Forecast, by Product Type 11.4.1. Human Serum Albumin 11.4.2. Recombinant Albumin 11.4.3. Bovine Serum Albumin 11.5. North America Albumin Market Value Share Analysis, by Application 11.6. North America Albumin Market Forecast, by Application 11.6.1. Drug Formulation 11.6.2. Drug Delivery 11.6.3. Vaccines 11.6.4. Medical Device Coating 11.6.5. Culture Medium & Stabilizer 11.6.6. Diagnostics 11.6.7. In Vitro Fertilization 11.7. North America Albumin Market Value Share Analysis, by End-User 11.8. North America Albumin Market Forecast, by End-User 11.8.1. Pharmaceutical & Biotechnology Industry 11.8.2. Research Institutes 11.9. North America Albumin Market Value Share Analysis, by Country 11.10. North America Albumin Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Albumin Market Analysis, by Country 11.12. U.S. Albumin Market Forecast, by Product Type 11.12.1. Human Serum Albumin 11.12.2. Recombinant Albumin 11.12.3. Bovine Serum Albumin 11.13. U.S. Albumin Market Forecast, by Application 11.13.1. Drug Formulation 11.13.2. Drug Delivery 11.13.3. Vaccines 11.13.4. Medical Device Coating 11.13.5. Culture Medium & Stabilizer 11.13.6. Diagnostics 11.13.7. In Vitro Fertilization 11.14. U.S. Albumin Market Forecast, by End-User 11.14.1. Pharmaceutical & Biotechnology Industry 11.14.2. Research Institutes 11.15. Canada Albumin Market Forecast, by Product Type 11.15.1. Human Serum Albumin 11.15.2. Recombinant Albumin 11.15.3. Bovine Serum Albumin 11.16. Steel Canada Albumin Market Forecast, by Application 11.16.1. Drug Formulation 11.16.2. Drug Delivery 11.16.3. Vaccines 11.16.4. Medical Device Coating 11.16.5. Culture Medium & Stabilizer 11.16.6. Diagnostics 11.16.7. In Vitro Fertilization 11.17. Canada Albumin Market Forecast, by End-User 11.17.1. Pharmaceutical & Biotechnology Industry 11.17.2. Research Institutes 11.18. North America Albumin Market Attractiveness Analysis 11.18.1. By Product Type 11.18.2. By Application 11.18.3. By End-User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Albumin Market Analysis 12.1. Key Findings 12.2. Europe Albumin Market Overview 12.3. Europe Albumin Market Value Share Analysis, by Product Type 12.4. Europe Albumin Market Forecast, by Product Type 12.4.1. Human Serum Albumin 12.4.2. Recombinant Albumin 12.4.3. Bovine Serum Albumin 12.5. Europe Albumin Market Value Share Analysis, by Application 12.6. Europe Albumin Market Forecast, by Application 12.6.1. Drug Formulation 12.6.2. Drug Delivery 12.6.3. Vaccines 12.6.4. Medical Device Coating 12.6.5. Culture Medium & Stabilizer 12.6.6. Diagnostics 12.6.7. In Vitro Fertilization 12.7. Europe Albumin Market Value Share Analysis, by End-User 12.8. Europe Albumin Market Forecast, by End-User 12.8.1. Pharmaceutical & Biotechnology Industry 12.8.2. Research Institutes 12.9. Europe Albumin Market Value Share Analysis, by Country 12.10. Europe Albumin Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Albumin Market Analysis, by Country 12.12. Germany Albumin Market Forecast, by Product Type 12.12.1. Human Serum Albumin 12.12.2. Recombinant Albumin 12.12.3. Bovine Serum Albumin 12.13. Germany Albumin Market Forecast, by Application 12.13.1. Drug Formulation 12.13.2. Drug Delivery 12.13.3. Vaccines 12.13.4. Medical Device Coating 12.13.5. Culture Medium & Stabilizer 12.13.6. Diagnostics 12.13.7. In Vitro Fertilization 12.14. Germany Albumin Market Forecast, by End-User 12.14.1. Pharmaceutical & Biotechnology Industry 12.14.2. Research Institutes 12.15. U.K. Albumin Market Forecast, by Product Type 12.15.1. Human Serum Albumin 12.15.2. Recombinant Albumin 12.15.3. Bovine Serum Albumin 12.16. U.K. Albumin Market Forecast, by Application 12.16.1. Drug Formulation 12.16.2. Drug Delivery 12.16.3. Vaccines 12.16.4. Medical Device Coating 12.16.5. Culture Medium & Stabilizer 12.16.6. Diagnostics 12.16.7. In Vitro Fertilization 12.17. U.K. Albumin Market Forecast, by End-User 12.17.1. Pharmaceutical & Biotechnology Industry 12.17.2. Research Institutes 12.18. France Albumin Market Forecast, by Product Type 12.18.1. Human Serum Albumin 12.18.2. Recombinant Albumin 12.18.3. Bovine Serum Albumin 12.19. France Albumin Market Forecast, by Application 12.19.1. Drug Formulation 12.19.2. Drug Delivery 12.19.3. Vaccines 12.19.4. Medical Device Coating 12.19.5. Culture Medium & Stabilizer 12.19.6. Diagnostics 12.19.7. In Vitro Fertilization 12.20. France Albumin Market Forecast, by End-User 12.20.1. Pharmaceutical & Biotechnology Industry 12.20.2. Research Institutes 12.21. Italy Albumin Market Forecast, by Product Type 12.21.1. Human Serum Albumin 12.21.2. Recombinant Albumin 12.21.3. Bovine Serum Albumin 12.22. Italy Albumin Market Forecast, by Application 12.22.1. Drug Formulation 12.22.2. Drug Delivery 12.22.3. Vaccines 12.22.4. Medical Device Coating 12.22.5. Culture Medium & Stabilizer 12.22.6. Diagnostics 12.22.7. In Vitro Fertilization 12.23. Italy Albumin Market Forecast, by End-User 12.23.1. Pharmaceutical & Biotechnology Industry 12.23.2. Research Institutes 12.24. Spain Albumin Market Forecast, by Product Type 12.24.1. Human Serum Albumin 12.24.2. Recombinant Albumin 12.24.3. Bovine Serum Albumin 12.25. Spain Albumin Market Forecast, by Application 12.25.1. Drug Formulation 12.25.2. Drug Delivery 12.25.3. Vaccines 12.25.4. Medical Device Coating 12.25.5. Culture Medium & Stabilizer 12.25.6. Diagnostics 12.25.7. In Vitro Fertilization 12.26. Spain Albumin Market Forecast, by End-User 12.26.1. Pharmaceutical & Biotechnology Industry 12.26.2. Research Institutes 12.27. Rest of Europe Albumin Market Forecast, by Product Type 12.27.1. Human Serum Albumin 12.27.2. Recombinant Albumin 12.27.3. Bovine Serum Albumin 12.28. Rest of Europe Albumin Market Forecast, by Application 12.28.1. Drug Formulation 12.28.2. Drug Delivery 12.28.3. Vaccines 12.28.4. Medical Device Coating 12.28.5. Culture Medium & Stabilizer 12.28.6. Diagnostics 12.28.7. In Vitro Fertilization 12.29. Rest Of Europe Albumin Market Forecast, by End-User 12.29.1. Pharmaceutical & Biotechnology Industry 12.29.2. Research Institutes 12.30. Europe Albumin Market Attractiveness Analysis 12.30.1. By Product Type 12.30.2. By Application 12.30.3. By End-User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Albumin Market Analysis 13.1. Key Findings 13.2. Asia Pacific Albumin Market Overview 13.3. Asia Pacific Albumin Market Value Share Analysis, by Product Type 13.4. Asia Pacific Albumin Market Forecast, by Product Type 13.4.1. Human Serum Albumin 13.4.2. Recombinant Albumin 13.4.3. Bovine Serum Albumin 13.5. Asia Pacific Albumin Market Value Share Analysis, by Application 13.6. Asia Pacific Albumin Market Forecast, by Application 13.6.1. Drug Formulation 13.6.2. Drug Delivery 13.6.3. Vaccines 13.6.4. Medical Device Coating 13.6.5. Culture Medium & Stabilizer 13.6.6. Diagnostics 13.6.7. In Vitro Fertilization 13.7. Asia Pacific Albumin Market Value Share Analysis, by End-User 13.8. Asia Pacific Albumin Market Forecast, by End-User 13.8.1. Pharmaceutical & Biotechnology Industry 13.8.2. Research Institutes 13.9. Asia Pacific Albumin Market Value Share Analysis, by Country 13.10. Asia Pacific Albumin Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Albumin Market Analysis, by Country 13.12. China Albumin Market Forecast, by Product Type 13.12.1. Human Serum Albumin 13.12.2. Recombinant Albumin 13.12.3. Bovine Serum Albumin 13.13. China Albumin Market Forecast, by Application 13.13.1. Drug Formulation 13.13.2. Drug Delivery 13.13.3. Vaccines 13.13.4. Medical Device Coating 13.13.5. Culture Medium & Stabilizer 13.13.6. Diagnostics 13.13.7. In Vitro Fertilization 13.14. China Albumin Market Forecast, by End-User 13.14.1. Pharmaceutical & Biotechnology Industry 13.14.2. Research Institutes 13.15. India Albumin Market Forecast, by Product Type 13.15.1. Human Serum Albumin 13.15.2. Recombinant Albumin 13.15.3. Bovine Serum Albumin 13.16. India Albumin Market Forecast, by Application 13.16.1. Drug Formulation 13.16.2. Drug Delivery 13.16.3. Vaccines 13.16.4. Medical Device Coating 13.16.5. Culture Medium & Stabilizer 13.16.6. Diagnostics 13.16.7. In Vitro Fertilization 13.17. India Albumin Market Forecast, by End-User 13.17.1. Pharmaceutical & Biotechnology Industry 13.17.2. Research Institutes 13.18. Japan Albumin Market Forecast, by Product Type 13.18.1. Human Serum Albumin 13.18.2. Recombinant Albumin 13.18.3. Bovine Serum Albumin 13.19. Japan Albumin Market Forecast, by Application 13.19.1. Drug Formulation 13.19.2. Drug Delivery 13.19.3. Vaccines 13.19.4. Medical Device Coating 13.19.5. Culture Medium & Stabilizer 13.19.6. Diagnostics 13.19.7. In Vitro Fertilization 13.20. Japan Albumin Market Forecast, by End-User 13.20.1. Pharmaceutical & Biotechnology Industry 13.20.2. Research Institutes 13.21. ASEAN Albumin Market Forecast, by Product Type 13.21.1. Human Serum Albumin 13.21.2. Recombinant Albumin 13.21.3. Bovine Serum Albumin 13.22. ASEAN Albumin Market Forecast, by Application 13.22.1. Drug Formulation 13.22.2. Drug Delivery 13.22.3. Vaccines 13.22.4. Medical Device Coating 13.22.5. Culture Medium & Stabilizer 13.22.6. Diagnostics 13.22.7. In Vitro Fertilization 13.23. ASEAN Albumin Market Forecast, by End-User 13.23.1. Pharmaceutical & Biotechnology Industry 13.23.2. Research Institutes 13.24. Rest of Asia Pacific Albumin Market Forecast, by Product Type 13.24.1. Human Serum Albumin 13.24.2. Recombinant Albumin 13.24.3. Bovine Serum Albumin 13.25. Rest of Asia Pacific Albumin Market Forecast, by Application 13.25.1. Drug Formulation 13.25.2. Drug Delivery 13.25.3. Vaccines 13.25.4. Medical Device Coating 13.25.5. Culture Medium & Stabilizer 13.25.6. Diagnostics 13.25.7. In Vitro Fertilization 13.26. Rest of Asia Pacific Albumin Market Forecast, by End-User 13.26.1. Pharmaceutical & Biotechnology Industry 13.26.2. Research Institutes 13.27. Asia Pacific Albumin Market Attractiveness Analysis 13.27.1. By Product Type 13.27.2. By Application 13.27.3. By End-User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Albumin Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Albumin Market Overview 14.3. Middle East & Africa Albumin Market Value Share Analysis, by Product Type 14.4. Middle East & Africa Albumin Market Forecast, by Product Type 14.4.1. Human Serum Albumin 14.4.2. Recombinant Albumin 14.4.3. Bovine Serum Albumin 14.5. Middle East & Africa Albumin Market Value Share Analysis, by Application 14.6. Middle East & Africa Albumin Market Forecast, by Application 14.6.1. Drug Formulation 14.6.2. Drug Delivery 14.6.3. Vaccines 14.6.4. Medical Device Coating 14.6.5. Culture Medium & Stabilizer 14.6.6. Diagnostics 14.6.7. In Vitro Fertilization 14.7. Middle East & Africa Albumin Market Value Share Analysis, by End-User 14.8. Middle East & Africa Albumin Market Forecast, by End-User 14.8.1. Pharmaceutical & Biotechnology Industry 14.8.2. Research Institutes 14.9. Middle East & Africa Albumin Market Value Share Analysis, by Country 14.10. Middle East & Africa Albumin Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Albumin Market Analysis, by Country 14.12. GCC Albumin Market Forecast, by Product Type 14.12.1. Human Serum Albumin 14.12.2. Recombinant Albumin 14.12.3. Bovine Serum Albumin 14.13. GCC Albumin Market Forecast, by Application 14.13.1. Drug Formulation 14.13.2. Drug Delivery 14.13.3. Vaccines 14.13.4. Medical Device Coating 14.13.5. Culture Medium & Stabilizer 14.13.6. Diagnostics 14.13.7. In Vitro Fertilization 14.14. GCC Albumin Market Forecast, by End-User 14.14.1. Pharmaceutical & Biotechnology Industry 14.14.2. Research Institutes 14.15. South Africa Albumin Market Forecast, by Product Type 14.15.1. Human Serum Albumin 14.15.2. Recombinant Albumin 14.15.3. Bovine Serum Albumin 14.16. South Africa Albumin Market Forecast, by Application 14.16.1. Drug Formulation 14.16.2. Drug Delivery 14.16.3. Vaccines 14.16.4. Medical Device Coating 14.16.5. Culture Medium & Stabilizer 14.16.6. Diagnostics 14.16.7. In Vitro Fertilization 14.17. South Africa Albumin Market Forecast, by End-User 14.17.1. Pharmaceutical & Biotechnology Industry 14.17.2. Research Institutes 14.18. Rest of Middle East & Africa Albumin Market Forecast, by Product Type 14.18.1. Human Serum Albumin 14.18.2. Recombinant Albumin 14.18.3. Bovine Serum Albumin 14.19. Rest of Middle East & Africa Albumin Market Forecast, by Application 14.19.1. Drug Formulation 14.19.2. Drug Delivery 14.19.3. Vaccines 14.19.4. Medical Device Coating 14.19.5. Culture Medium & Stabilizer 14.19.6. Diagnostics 14.19.7. In Vitro Fertilization 14.20. Rest of Middle East & Africa Albumin Market Forecast, by End-User 14.20.1. Pharmaceutical & Biotechnology Industry 14.20.2. Research Institutes 14.21. Middle East & Africa Albumin Market Attractiveness Analysis 14.21.1. By Product Type 14.21.2. By Application 14.21.3. By End-User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Albumin Market Analysis 15.1. Key Findings 15.2. South America Albumin Market Overview 15.3. South America Albumin Market Value Share Analysis, by Product Type 15.4. South America Albumin Market Forecast, by Product Type 15.4.1. Human Serum Albumin 15.4.2. Recombinant Albumin 15.4.3. Bovine Serum Albumin 15.5. South America Albumin Market Value Share Analysis, by Application 15.6. South America Albumin Market Forecast, by Application 15.6.1. Drug Formulation 15.6.2. Drug Delivery 15.6.3. Vaccines 15.6.4. Medical Device Coating 15.6.5. Culture Medium & Stabilizer 15.6.6. Diagnostics 15.6.7. In Vitro Fertilization 15.7. South America Albumin Market Value Share Analysis, by End-User 15.8. South America Albumin Market Forecast, by End-User 15.8.1. Pharmaceutical & Biotechnology Industry 15.8.2. Research Institutes 15.9. South America Albumin Market Value Share Analysis, by Country 15.10. South America Albumin Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Albumin Market Analysis, by Country 15.12. Brazil Albumin Market Forecast, by Product Type 15.12.1. Human Serum Albumin 15.12.2. Recombinant Albumin 15.12.3. Bovine Serum Albumin 15.13. Brazil Albumin Market Forecast, by Application 15.13.1. Drug Formulation 15.13.2. Drug Delivery 15.13.3. Vaccines 15.13.4. Medical Device Coating 15.13.5. Culture Medium & Stabilizer 15.13.6. Diagnostics 15.13.7. In Vitro Fertilization 15.14. Brazil Albumin Market Forecast, by End-User 15.14.1. Pharmaceutical & Biotechnology Industry 15.14.2. Research Institutes 15.15. Mexico Albumin Market Forecast, by Product Type 15.15.1. Human Serum Albumin 15.15.2. Recombinant Albumin 15.15.3. Bovine Serum Albumin 15.16. Mexico Albumin Market Forecast, by Application 15.16.1. Drug Formulation 15.16.2. Drug Delivery 15.16.3. Vaccines 15.16.4. Medical Device Coating 15.16.5. Culture Medium & Stabilizer 15.16.6. Diagnostics 15.16.7. In Vitro Fertilization 15.17. Mexico Albumin Market Forecast, by End-User 15.17.1. Pharmaceutical & Biotechnology Industry 15.17.2. Research Institutes 15.18. Rest of South America Albumin Market Forecast, by Product Type 15.18.1. Human Serum Albumin 15.18.2. Recombinant Albumin 15.18.3. Bovine Serum Albumin 15.19. Rest of South America Albumin Market Forecast, by Application 15.19.1. Drug Formulation 15.19.2. Drug Delivery 15.19.3. Vaccines 15.19.4. Medical Device Coating 15.19.5. Culture Medium & Stabilizer 15.19.6. Diagnostics 15.19.7. In Vitro Fertilization 15.20. Rest of South America Albumin Market Forecast, by End-User 15.20.1. Pharmaceutical & Biotechnology Industry 15.20.2. Research Institutes 15.21. South America Albumin Market Attractiveness Analysis 15.21.1. By Product Type 15.21.2. By Application 15.21.3. By End-User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Albumedix A/S 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Albumin Therapeutics, LLC 16.3.3. Biotest AG 16.3.4. CSL Behring LLC 16.3.5. Grifols International, S.A. 16.3.6. HiMedia Laboratories Pvt. Ltd. 16.3.7. InVitria 16.3.8. Medxbio Pte Ltd. 16.3.9. Octapharma AG 16.3.10. RayBiotech, Inc. 16.3.11. SeraCare Life Sciences 16.3.12. Sigma-Aldrich Co. 16.3.13. Akron Biotech 16.3.14. Baxter International Inc. 16.3.15. Celgene Corporation 16.3.16. Grifols SA 16.3.17. Merck KGaA 16.3.18. China Biologic Products Inc. 16.3.19. Shire Plc 16.3.20. Ventria Bioscience 16.3.21. Thermo Fisher Scientific 16.3.22. Novozymes A/S. 17. Primary Key Insights

About This Report

Report ID 37220
Category Healthcare
Published Date Nov 2019
Updated Date Oct 2020
Contact Us